Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes
Eun Seok Kang1, Hae Jin Kim, Yoo Mee Kim
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. endohclee@yumc.yonsei.ac.kr
Insights
High sensitivity C-reactive protein (hsCRP) levels in type 2 diabetes patients correlate with cardiovascular disease risk factors and carotid intima-media thickness. This suggests hsCRP may help predict accelerated atherosclerosis in this population.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- High sensitivity C-reactive protein (hsCRP) is a sensitive marker for cardiovascular disease risk.
- Type 2 diabetes patients often exhibit elevated serum hsCRP levels compared to non-diabetic individuals.
- Factors influencing hsCRP levels in type 2 diabetes require further investigation.
Purpose of the Study:
- To evaluate the association between serum hsCRP levels and cardiovascular disease risk factors in type 2 diabetic subjects.
- To determine the relationship between serum hsCRP levels and carotid intima-media thickness (IMT) in type 2 diabetes.
Main Methods:
- 105 type 2 diabetes patients (excluding severe cardiovascular disease) underwent carotid ultrasonography for IMT assessment.
- Serum hsCRP concentrations were measured in all participants.
- Data analysis focused on correlations between hsCRP, IMT, and various risk factors.
Main Results:
- Serum hsCRP levels showed significant correlations with carotid IMT (mean and maximal, left and right sides).
- hsCRP also correlated with body mass index, waist circumference, waist-hip ratio, total cholesterol, triglycerides, and LDL cholesterol.
- These findings indicate a link between inflammation, atherosclerosis, and metabolic factors in type 2 diabetes.
Conclusions:
- Serum hsCRP levels are significantly correlated with carotid IMT in type 2 diabetic patients.
- hsCRP is associated with multiple cardiovascular disease risk factors in this population.
- Elevated hsCRP may serve as a predictor of accelerated atherosclerosis in individuals with type 2 diabetes.
Background:
High sensitivity C-reactive protein (hsCRP) is more sensitive than standard C-reactive protein (CRP) assay in evaluating the risk of coronary heart disease and other atherosclerotic events. By this time, there are several reports that type 2 diabetic subjects have higher serum levels of hsCRP than those of non-diabetic subjects. However, there are few reports about factors which have influence upon the level of serum hsCRP in type 2 diabetic subjects. We had evaluated the association of serum hsCRP level with risk factors of cardiovascular diseases and carotid intima-media thickness (IMT) in type 2 diabetic subjects.
Methods:
One hundred and five patients (59 men and 46 women) with type 2 diabetes were recruited. Subjects with severe cardiovascular diseases were excluded. All subjects were undergone carotid ultrasonography for evaluation of carotid IMT. Serum hsCRP concentrations were measured.
Results:
Serum hsCRP level was correlated with mean left IMT (r = 0.366, P = 0.003), maximal left IMT (r = 0.370, P = 0.002), mean right IMT (r = 0.281, P = 0.023) and maximal right IMT (r = 0.370, P = 0.002), body mass index (r = 0.377, P < 0.001), waist circumference (r = 0.342, P < 0.001), waist-hip ratio (r = 0.229, P = 0.020), serum total cholesterol (r = 0.202, P = 0.024), serum triglyceride (r = 0.292, P = 0.022) and serum low-density lipoprotein (r = 0.133, P = 0.044).
Conclusion:
Our result shows that serum hsCRP level is correlated with carotid IMT and the risk factors of cardiovascular diseases and may be useful to predict accelerated atherosclerotic process in type 2 diabetic subjects.
Related Concept Videos
Coronary Artery Disease I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
